Pfizer Reports Positive Phase 3 Results for Antibiotic Combi

By Colin Kellaher


Pfizer on Thursday reported positive results from a pair of Phase 3 studies evaluating the efficacy, safety and tolerability of the novel investigational antibiotic... | June 1, 2023

Related Keywords

Canada , China , New York , United States , Colin Kellaher , European Union , Pfizer , Dow Jones , Nc Stock Exchange , News , Information , Press Release , Y , Colin , Kellaher , N , Hursday , Eported , Positive , Results , Rom , Hair , F , Hase , , Studies , Valuating , The , Safety , End , Tolerability , Novel , Nvestigational Pfe Us7170811035 ,